drugset

drugset / Trial / NCT00297037

Pimecrolimus Cream for Oral Lichen Planus

NCT00297037 ↗

Phase 2 Completed 21 enrolled University of Utah Novartis · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

Study investigating the use of pimecrolimus 1% cream for oral lichen planus

Timeline

Start: 2005-08
Primary completion: 2009-02
Completion: 2009-02

Publications

Results McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM. Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1061-7. doi: 10.1111/j.1468-3083.2010.03923.x. Epub 2010 Dec 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pimecrolimus	Small molecule	1 %	Topical

Indications